The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Classon Rolf A since year 2005.
The trader's CIK number is 1030325.
At the time of this reporting, Classon Rolf A is the Director of Enzon Pharmaceuticals Inc .
(stock ticker symbol ENZN).
See this page for all insider trading activities at Enzon Pharmaceuticals Inc .
Note that in the past CLASSON ROLF A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Classon Rolf A since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-11-17
ENZN
Enzon Pharmaceuticals Inc
Purchase
10,000
4.04
40,400
2008-08-11
MIL
Millipore Corp /ma
Purchase
2,500
71.37
178,414
2008-07-01
ENZN
Enzon Pharmaceuticals Inc
Option Exercise
1,255
.00
0
2008-07-02
ENZN
Enzon Pharmaceuticals Inc
Option Exercise
3,172
.00
0
2008-07-03
ENZN
Enzon Pharmaceuticals Inc
Option Exercise
1,105
.00
0
2008-05-04
MIL
Millipore Corp /ma
Option Exercise
207
.00
0
2008-04-26
MIL
Millipore Corp /ma
Option Exercise
206
.00
0
2007-07-01
ENZN
Enzon Pharmaceuticals Inc
Option Exercise
1,255
.00
0
2007-07-03
ENZN
Enzon Pharmaceuticals Inc
Option Exercise
1,105
.00
0
2007-04-26
MIL
Millipore Corp /ma
Option Exercise
207
.00
0
2007-03-09
ISTA
Ista Pharmaceuticals Inc
Option Exercise
16,000
5.82
93,120
2006-12-11
ENZN
Enzon Pharmaceuticals Inc
Option Exercise
30,000
2.94
88,125
2006-12-11
ENZN
Enzon Pharmaceuticals Inc
Sale
30,000
8.23
246,810
2006-07-01
ENZN
Enzon Pharmaceuticals Inc
Option Exercise
1,255
.00
0
2005-11-22
AUXL
Auxilium Pharmaceuticals Inc
Purchase
5,000
5.09
25,450
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Classon Rolf A
(Director of Enzon Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.